Literature DB >> 12505044

Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis.

Daniel Myers1, Diana Farris, Angela Hawley, Shirley Wrobleski, Amy Chapman, Lloyd Stoolman, Randy Knibbs, Robert Strieter, Thomas Wakefield.   

Abstract

BACKGROUND: This study characterizes venous thrombosis in the mouse and examines the important role that the adhesion molecules P-selectin and E-selectin and the anti-inflammatory cytokine interleukin-10 (IL-10) play in the thrombotic process.
MATERIALS AND METHODS: C57BL/6 (wild-type) mice in a natural history protocol (Phase I) and gene-targeted (KO) mice for P-selectin, E-selectin, P/E-selectin, and IL-10 in a follow-up protocol (Phase II) were studied. Inferior vena caval thrombosis was produced by ligation just below the renal veins, and mice were sacrificed and evaluated at various time points up to 12 days later.
RESULTS: Phase I: A significant increase in neutrophils on day 2 and in monocytes on day 6 postthrombosis was found in ligated vs sham animals. An associated significant increase in vein wall P-selectin mRNA (6 h, day 2) and an increase in protein (6 h through day 6) were found, while E-selectin mRNA was significantly increased (day 2 through day 6), with a smaller increase in E-selectin protein. IL-10 mRNA increased significantly later (day 2 through day 9), with the values increasing progressively. A positive correlation existed (r = 0.77) between neutrophils and thrombosis at day 2. PHASE II: The E-selectin and P/E-selectin double-KO mice showed the least thrombus at day 2 vs wild-type clotted mice, P < 0.01. Additionally, P/E-KO mice demonstrated the lowest inflammatory cell extravasation into the vein wall at day 2.
CONCLUSIONS: This study demonstrates an acute to chronic inflammatory response in the vein wall associated with venous thrombosis. Inhibition of selectins decreased thrombus formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505044     DOI: 10.1006/jsre.2002.6552

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  50 in total

1.  Microparticles during sepsis: target, canary or cure?

Authors:  Lara Zafrani; Can Ince; Peter S T Yuen
Journal:  Intensive Care Med       Date:  2013-08-08       Impact factor: 17.440

Review 2.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

Review 3.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

4.  Antithrombotic effects of heme-degrading and heme-binding proteins.

Authors:  Karl A Nath; Joseph P Grande; John D Belcher; Vesna D Garovic; Anthony J Croatt; Matthew L Hillestad; Michael A Barry; Meryl C Nath; Raymond F Regan; Gregory M Vercellotti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-31       Impact factor: 4.733

5.  Endotoxaemia-augmented murine venous thrombosis is dependent on TLR-4 and ICAM-1, and potentiated by neutropenia.

Authors:  Andrea T Obi; Elizabeth Andraska; Yogendra Kanthi; Chase W Kessinger; Megan Elfline; Cathy Luke; Teruna J Siahaan; Farouc A Jaffer; Thomas W Wakefield; Peter K Henke
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

Review 6.  Critical review of mouse models of venous thrombosis.

Authors:  Jose A Diaz; Andrea T Obi; Daniel D Myers; Shirley K Wrobleski; Peter K Henke; Nigel Mackman; Thomas W Wakefield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03       Impact factor: 8.311

Review 7.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

8.  P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.

Authors:  Eduardo Ramacciotti; Daniel D Myers; Shirley K Wrobleski; K Barry Deatrick; Frank J Londy; John E Rectenwald; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-04       Impact factor: 3.944

9.  Induction of heme oxygenase-1 is a beneficial response in a murine model of venous thrombosis.

Authors:  Michal J Tracz; Julio P Juncos; Joseph P Grande; Anthony J Croatt; Allan W Ackerman; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis.

Authors:  Yi-Dan Li; Bu-Qing Ye; Sheng-Xi Zheng; Jin-Tao Wang; Jian-Guo Wang; Ming Chen; Ji-Guo Liu; Xin-Hui Pei; Li-Jing Wang; Zhi-Xin Lin; Kalpna Gupta; Nigel Mackman; Arne Slungaard; Nigel S Key; Jian-Guo Geng
Journal:  J Biol Chem       Date:  2008-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.